In conclusion, our data suggest that sCD163 is a promising biomarker associated with inflammation in PD, thereby supporting a role for α‐syn in monocyte activation and sCD163 shedding that could have direct consequences for α‐syn processing. This evidence concerns the gene CD163 and Parkinson disease.